Bio-Techne Corporation (TECH) SEC Filings https://investors.bio-techne.com/all-sec-filings/rss Bio-Techne Corporation (TECH) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_f0b975705403ab5250b3c1bdea3a82ff/biotechne/files/bio-techne-logo.png Bio-Techne Corporation Logo https://investors.bio-techne.com Equisolve Investor Relations Suite <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://investors.bio-techne.com/all-sec-filings?page=1#document-4138-0000914190-26-000139 Thu, 24 Sep 26 16:53:22 -0400 https://investors.bio-techne.com/all-sec-filings?page=1#document-4138-0000914190-26-000139 <![CDATA[8-K - Current report]]> https://investors.bio-techne.com/all-sec-filings?page=1#document-4136-0001140361-26-037450 Wed, 23 Sep 26 17:48:11 -0400 https://investors.bio-techne.com/all-sec-filings?page=1#document-4136-0001140361-26-037450 <![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]> https://investors.bio-techne.com/all-sec-filings?page=1#document-4135-0001140361-26-036500 Mon, 14 Sep 26 16:48:13 -0400 https://investors.bio-techne.com/all-sec-filings?page=1#document-4135-0001140361-26-036500 <![CDATA[8-K - Current report]]> https://investors.bio-techne.com/all-sec-filings?page=1#document-4134-0001140361-26-036499 Mon, 14 Sep 26 16:47:50 -0400 https://investors.bio-techne.com/all-sec-filings?page=1#document-4134-0001140361-26-036499 <![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]> https://investors.bio-techne.com/all-sec-filings?page=1#document-4133-0001140361-26-036072 Wed, 09 Sep 26 17:08:52 -0400 https://investors.bio-techne.com/all-sec-filings?page=1#document-4133-0001140361-26-036072 <![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]> https://investors.bio-techne.com/all-sec-filings?page=1#document-4132-0001140361-26-035490 Wed, 02 Sep 26 16:29:56 -0400 https://investors.bio-techne.com/all-sec-filings?page=1#document-4132-0001140361-26-035490 <![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]> https://investors.bio-techne.com/all-sec-filings?page=1#document-4131-0001140361-26-034325 Tue, 25 Aug 26 16:23:47 -0400 https://investors.bio-techne.com/all-sec-filings?page=1#document-4131-0001140361-26-034325 <![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]> https://investors.bio-techne.com/all-sec-filings?page=1#document-4120-0001104659-26-100322 Mon, 24 Aug 26 16:32:53 -0400 https://investors.bio-techne.com/all-sec-filings?page=1#document-4120-0001104659-26-100322 <![CDATA[DEFM14A - Definitive proxy statement relating to merger or acquisition]]> https://investors.bio-techne.com/all-sec-filings?page=1#document-4119-0001140361-26-033911 Thu, 20 Aug 26 17:20:06 -0400 https://investors.bio-techne.com/all-sec-filings?page=1#document-4119-0001140361-26-033911 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://investors.bio-techne.com/all-sec-filings?page=1#document-4118-0000914190-26-000133 Wed, 19 Aug 26 16:51:42 -0400 https://investors.bio-techne.com/all-sec-filings?page=1#document-4118-0000914190-26-000133